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Abstract
Background: Extracellular signaling through receptors for neurotrophins mediates diverse neuronal
functions, including survival, migration and differentiation in the central nervous system, but the
transcriptional targets and regulators that mediate these diverse neurotrophin functions are not well
understood.
Results: We have identified the immediate-early (IE) genes Fos, Egr1 and Egr2 as transcriptional targets of
brain derived neurotrophic factor (BDNF)/TrkB signaling in primary cortical neurons, and show that the
Fos serum response element area responds to BDNF/TrkB in a manner dependent on a combined C/EBP-
Ebox element. The Egr1 and Egr2 promoters contain homologous regulatory elements. We found that C/
EBPα/β and NeuroD formed complexes in vitro and in vivo, and were recruited to all three homologous
promoter regions. C/EBPα and NeuroD co-operatively activated the Fos promoter in transfection assays.
Genetic depletion of Trk receptors led to impaired recruitment of C/EBPs and NeuroD in vivo, and
elimination of Cebpa and Cebpb alleles reduced BDNF induction of Fos, Egr1 and Egr2 in primary neurons.
Finally, defective differentiation of cortical dendrites, as measured by MAP2 staining, was observed in both
compound Cebp and Ntrk knockout mice.
Conclusion: We here identify three IE genes as targets for BDNF/TrkB signaling, show that C/EBPα and
-β are recruited along with NeuroD to target promoters, and that C/EBPs are essential mediators of Trk
signaling in cortical neurons. We show also that C/EBPs and Trks are required for cortical dendrite
differentiation, consistent with Trks regulating dendritic differentiation via a C/EBP-dependent mechanism.
Finally, this study indicates that BDNF induction of IE genes important for neuronal function depends on
transcription factors (C/EBP, NeuroD) up-regulated during neuronal development, thereby coupling the
functional competence of the neuronal cells to their differentiation.
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Background
The influence of growth factors, as well as transcription
factors, on cell fate determination and differentiation is
well established. Brain derived neurotrophic factor
(BDNF) affects neuronal cortical development by signal-
ing through its cognate tyrosine kinase receptor, TrkB.
Together they regulate many cellular functions during and
after the development of the nervous system [1-4]. In par-
ticular, we have reported that TrkB, via the activation of
the Ras/Mitogen activated protein kinase (MAPK) and
Phosphatidylinositol-3 kinase/cellular homolog of the
viral oncogene v-Akt (PI3K/AKT) pathways, regulates
functions throughout the formation of the cerebral cortex,
including neuronal dendritic differentiation [5]. While
several transcription factors have been found to respond
to activation of TrkB and other Trk family receptors, it is
not well understood how Trk signaling interacts with the
transcription factors regulating neuronal differentiation
to activate specific target genes required during the differ-
ent phases of neuronal development and, subsequently,
in neuronal function.
The neurogenic basic helix-loop-helix (bHLH) transcrip-
tion factors have been shown to be important intrinsic
regulators of neural fate determination and differentia-
tion. There are at least two categories of bHLH transcrip-
tion factors that mediate neurogenesis: proneural bHLHs
(Neurogenins and Mash family proteins), which are
involved in initiating neurogenesis, and neuronal differ-
entiation factors (members of the NeuroD/Nex family),
which are important for terminal differentiation. Studies
in mice lacking NeuroD/Nex family members indicate
that they are required not only for the survival of early dif-
ferentiating granule neurons in the hippocampus and cer-
ebellum, but also for their terminal differentiation [6,7].
Specifically, NeuroD selectively promotes dendrite, but
not axonal, morphogenesis in granule neurons through
its phosphorylation at distinct sites by CamKII [8]. These
factors form heterodimers with ubiquitously expressed
bHLH proteins, such as E12 and E47, and activate gene
expression programs through interaction, via their basic
domain, with DNA sequences containing the core hexa-
nucleotide motif CANNTG, known as the Ebox [9,10]. It
is still unknown which extracellular signals or intracellu-
lar mechanisms are involved in the regulation of bHLH
factor function.
The CCAAT/enhancer binding protein (C/EBP) family of
transcription factors couples growth factor signal trans-
duction with numerous cellular responses, including cel-
lular differentiation in a variety of non-neuronal tissues
[11,12]. The expression of C/EBPs has also been found to
change during a number of physiological and pathophys-
iological conditions in response to extracellular signals,
such as hormones, mitogens, and cytokines [12].
Recently, a Mitogen and extracellular signal regulated
kinase (MEK)-C/EBP signaling cascade has been impli-
cated in the commitment of progenitor cells toward a neu-
ronal fate in vitro through the inhibition of either MEK or
C/EBPs using dominant negative forms [13]. Paquin et al.
[14], using in utero electroporation to manipulate cortical
precursors, have suggested that MEK-mediated phosphor-
ylation of C/EBPs is essential for neuronal fate determina-
tion. Thus far, however, no genetic model has
demonstrated an effect for MEK1/2 or C/EBPs on neuro-
nal lineage commitment or differentiation.
We here identify Fos, Egr1 and Egr2 as genes that are regu-
lated by BDNF/TrkB in a C/EBP-dependent manner. We
identify a novel complex between C/EBPα/β and NeuroD,
and find that in vivo, these factors are recruited to the Fos,
Egr1  and  Egr2  promoters in a Trk-dependent manner.
Genetic C/EBP depletion leads to a cortical dendritic neu-
ronal differentiation defect, reminiscent of that seen in the
absence of multiple TrkB/C alleles, consistent with the
idea that Trk signaling through C/EBP-NeuroD complexes
mediates terminal cortical neuronal differentiation in vivo.
Results
BDNF induces Egr1, Egr2 and Fos expression in primary 
cortical neurons
To identify genes regulated by BDNF signaling through
TrkB in neuronal cells, primary cortical neurons derived
from E15.5 embryonic forebrain (when neurogenesis is at
its peak) were stimulated with BDNF and their gene
expression compared to that of untreated control cultures
by microarray analysis. Among the most highly regulated
genes was a group encoding immediate-early (IE) tran-
scription factors that consisted of Egr1, Egr2 and Fos. For
all three it was found that BDNF induction was reduced
when the binding site for the Shc adaptor on the TrkB
receptor was mutated (for this mouse strain see [5,15],
and Materials and methods), consistent with a common
regulatory mechanism underlying their upregulation (Fig-
ure 1a). The Shc site-dependent induction of these genes
was confirmed by quantitative real time PCR (qRT-PCR)
(Figure 1b–d).
A combined C/EBP site-E-box mediates Fos induction by 
BDNF
In order to identify the transcriptional mechanism by
which BDNF induces IE gene transcription we initially
established that a reporter construct carrying 700 base-
pairs (bp) of the Fos  promoter was induced by BDNF
when transiently transfected into cultures of primary cor-
tical neurons (Figure 2a). We next analyzed the role of the
area of the Fos promoter surrounding the serum response
element (SRE), as this is the most highly conserved part of
the proximal Fos promoter. The SRE area contains over-
lapping binding sites for serum response factor (SRF), C/Neural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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EBP, E-proteins and activating protein-1 (AP-1)/activating
transcription factor (ATF). By transient transfection analy-
sis, the simultaneous mutation of the Ebox and C/EBP site
(see supplementary Figure 1 in Additional data file 1 and
Supplemental materials and methods in Additional data
file 2 for analysis) was found to significantly decrease pro-
moter induction by BDNF (Figure 2b). We determined
that both Cebpa and Cebpb, as well as Neurod (encoding
the Ebox protein Beta2/NeuroD), were upregulated in
neuroblasts cultured under neural differentiation condi-
tions (Figure 3a–d), and that C/EBPα and NeuroD coop-
erated in Fos promoter activation, in a manner dependent
on the presence of their cognate binding sites, in a heter-
ologous cell line not expressing these proteins (Figure 3e).
Here it should be noticed that other C/EBPα and NeuroD
sites might be present in the promoter or in the vector
backbone, providing residual activation after mutation of
the identified C/EBPα and NeuroD sites.
IE gene expression upon BDNF stimulation of primary cortical neurons Figure 1
IE gene expression upon BDNF stimulation of primary cortical neurons. (a) Comparison of selected group of genes between 
trkB+/+ and trkBSHC/SHC mutant mice. The mRNA for the Affymetrix analysis was obtained from E15.5 primary cortical neurons 
with +/+ or TrkBSHC receptors that were either left unstimulated or stimulated with 50 ng/ml of BDNF for 1 hour after 1DIV. 
The fold change was averaged from three independent experiments. (b-d) qRT-PCR analysis of the selected BDNF regulated 
genes. Total mRNA obtained from trkB+/+ or trkBSHC/SHC primary cortical neurons, either left untreated or treated with 50 ng/ml 
of BDNF at different time points, were analyzed by qRT-PCR using primers specific for Egr1 (b), Fos (c), and Egr2 (d). After 
normalization to GAPDH, mRNA levels were expressed relative to the levels obtained from wild-type unstimulated cortical 
neurons, which were given the arbitrary value of 1. Average values and standard errors were obtained from three independent 
animals.
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A combined C/EBP binding site-E-box mediates Fos induction by BDNF/TrkB signaling in primary cortical neurons Figure 2
A combined C/EBP binding site-E-box mediates Fos induction by BDNF/TrkB signaling in primary cortical neurons. (a) Time 
course of luciferase activity based upon BDNF stimulation (50 ng/ml) of E15.5 wild-type (wt) cortical neurons transfected with 
a human Fos (hFos) promoter luciferase reporter plasmid (the proximal region of the Fos promoter in mouse and human is 
identical; see supplemental Figure 2a in Additional data file 1) and a pRSV-β-gal plasmid. Maximum luciferase activity was found 
between 2 and 4 hours of BDNF stimulation. (b) The combined C/EBP and Ebox sites are fundamental for the activation of the 
Fos promoter downstream of BDNF/TrkB. E15.5 wild-type primary cortical neurons were transfected with either wild-type or 
mutated Fos promoter luciferase reporter plasmids and pRSV-β-gal, and stimulated with 50 ng/ml of BDNF for 2 hours. Data 
shown are the average of three independent experiments, and results are indicated as the mean ± standard error. Cells trans-
fected with a Fos promoter mutated in both the C/EBP and the Ebox binding sites (pMcebp/ebox) showed a significant decrease 
in luciferase activity (*p < 0.005 relative to pWT). Instead, cortical neurons transfected with a plasmid mutated in the SRE and 
C/EBP binding site (pMSRF/cebp) revealed a significant increment in the activation of the promoter (*p < 0.005 relative to 
pWT). No significant difference in luciferase activity was observed between the wild-type Fos promoter (pWT) and the Fos 
promoter mutated at the Ebox alone (pMebox).
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C/EBPα/β and NeuroD transcription factors are co-expressed in neurons and cooperate to activate the Fos promoter Figure 3
C/EBPα/β and NeuroD transcription factors are co-expressed in neurons and cooperate to activate the Fos promoter. (a,b) 
Immunocytochemical analysis of cortical neuron progenitors cultured at E12.5, and stained with Nestin antibodies after 2DIV 
(a) or antibodies against the differentiation marker MAP2 after 4DIV (b). (c) RT-PCR analysis of Cebpa/b and Neurod in cortical 
progenitors. Primary cortical neuron progenitors from two different preparations were cultured at E12.5 and harvested for 
total mRNA after 2DIV (lanes 1 and 2), 4DIV (lanes 3 and 4), or 6DIV (lanes 5 and 6). Ubiquitin was used to control the levels 
of mRNA. Lanes 7 and 8 are mRNA samples without reverse transcriptase (RT). Lane 9, no template. (d) RT-PCR shown in (c) 
was quantified by densitometric analysis and is shown as the ratio of transcription factor (TF) to ubiquitin expression level. (e) 
Cooperation between C/EBPα and NeuroD transcription factors in the activation of the Fos promoter. NIH3T3 cells were 
transfected with either a wild-type Fos reporter plasmid (pWT, blue bars) or a reporter plasmid in which both the C/EBP and 
the Ebox binding sites were mutated (pMcebp/ebox, red bars), in the absence (lanes 1 and 5) or presence of a plasmid contain-
ing either C/EBPα (lanes 2 and 6), NeuroD (lanes 3 and 7) or a combination of both plasmids C/EBPα and NeuroD (lanes 4 and 
8). Co-transfection of C/EBPα and NeuroD significantly increased the activation of the wild-type Fos promoter (lane 4) com-
pared to C/EBPα or NeuroD alone (p < 0.0001 in both cases). This cooperation was significantly reduced (p < 0.0001) upon 
mutation of the C/EBP and Ebox binding sites (lane 8). Luciferase activity was normalised to β-gal activity. The relative luci-
ferase activity represents the mean value of at least four independent experiments.
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C/EBPs and NeuroD are recruited to IE gene promoters in 
vivo
Sequence alignment identified homologies to the Fos SRE
area in the Egr1 and Egr2 promoters (supplemental Figure
2 in Additional data file 1). To understand if these homol-
ogous promoter regions bound C/EBPs and NeuroD in
neuronal cells in vivo, chromatin immunoprecipitation
(ChIP) analysis was performed on embryonic forebrains.
This showed that C/EBPα, C/EBPβ and NeuroD were all
present on the three homologous promoter regions (Fig-
ure 4a, c, d, f–h). As a control for specificity of the ChIP, a
similar analysis was performed on two unrelated
sequences derived from the Fos  3' untranslated region
(UTR) and Egr1 exon 4; these regions showed no detecta-
ble binding of C/EBPs or NeuroD, whereas antibodies
against histone 3 (H3) and acetyl-H3 (Ac-H3) were able
to precipitate these amplicons, confirming the quality of
the input chromatin (Figure 4b, e).
C/EBPs mediate BDNF induction of IE genes in primary 
cortical neurons
The above analysis showed that the Fos, Egr1 and Egr2 pro-
moters contain homologous regulatory sequences, and
that all three recruit C/EBPα, -β and NeuroD. To deter-
mine whether C/EBPs play a direct role in the BDNF regu-
lation of these genes, we cultured primary cortical
neurons from mice carrying two or three null alleles of the
Cebpa and Cebpb genes (Figure 5a–c); inactivation of all
four Cebpa and Cebpb alleles leads to embryonic lethality
at E10.5 [16]. This analysis showed that a significant
decrease in expression after BDNF stimulation was
observed already in Cebpa+/-Cebpb+/- cells, whereas further
loss of an additional allele (Cebpa+/-Cebpb-/- or  Cebpa-/-
Cebpb+/- cells) led to a further reduction, resulting in loss
of 70% to 90% of the BDNF-induced level of gene expres-
sion. This was not due to loss of BDNF/TrkB signaling, as
BDNF-mediated induction of the MAPK pathway (as
measured by p42/p44 MAPK phosphorylation) and the
PI3K/AKT pathway (as measured by AKT phosphoryla-
tion) were unaffected by loss of Cebpa and Cebpb alleles
(Figure 5d).
Trk signaling regulates promoter recruitment
The above results are consistent with Trk receptor signal-
ing regulating either the recruitment or the activity of C/
EBP and NeuroD transcription factors to target promoters.
The major Trk receptors expressed in the developing cen-
tral nervous system (CNS) are TrkB and TrkC, which func-
tion in a redundant manner in promoting neuronal
survival during CNS development [17]. To address the
role of Trk signaling in C/EBP and NeuroD promoter
recruitment we performed ChIP experiments on newborn
forebrains of mice lacking TrkB and one allele of the gene
encoding TrkC (Ntrk2-/-Ntrk3+/- mice), thereby substan-
tially lowering the level of neurotrophin/Trk signaling in
the developing CNS. These experiments showed that the
amount of C/EBPs and NeuroD present on the Fos, Egr1
and Egr2 promoters was significantly lower in forebrains
where Trk signaling was reduced compared to wild-type
forebrain (Figure 6a–c) or mouse forebrain lacking only
TrkB (which showed an intermediate phenotype, data not
shown), whereas ChIP for H3 (a control for chromatin
quality) did not show any difference (Figure 6d). Impor-
tantly, expression of Cebpa, Cebpb and Neurod, as meas-
ured by qRT-PCR, was unaffected by the reduced Trk
receptor signaling (Figure 6e).
C/EBPα and NeuroD form a complex in vitro and in vivo
While the Fos promoter contains consensus-binding sites
for both C/EBP and Ebox proteins, a canonical consensus
Ebox is not present in the Egr1 or Egr2 SRE homology
regions. This, along with the observed correlation
between C/EBP and NeuroD promoter recruitment, sug-
gests that the two factors are recruited as a complex
through a cognate binding site for one of the two (most
likely a C/EBP). To determine whether C/EBPα and Neu-
roD were able to associate we co-transfected Q2bn cells
with expression vectors for FLAG-tagged C/EBPα and
Myc-tagged NeuroD and performed co-immopreciptia-
tion analysis. This showed that Myc-NeuroD was effi-
ciently co-precipitated with FLAG-C/EBPα, demonstrating
that the two factors are able to form a complex (Figure
7a). To address the issue of whether such a complex exists
under physiological conditions in neuronal cells we used
a mouse strain in which a tandem affinity purification
(TAP) tag [18] has been fused to the carboxyl terminus of
C/EBPα. The TAP-tag contains an immunoglobulin (Ig)-
binding domain from S. aureus protein A, which allows
tagged proteins to selectively bind to a rabbit IgG-agarose
matrix. Thus, nuclear extracts from E16.5 forebrain (a
time point when the forebrain is enriched in neuronal
cells) of mice heterozygous for the Cebpa TAP allele (Ceb-
paT/+ mice) and wild-type controls were subjected to IgG-
agarose pull-down and retained protein was analyzed for
the presence of NeuroD by western blotting. As expected,
the TAP-tagged C/EBPα isoforms were present in the pull-
down of CebpaT/+ lysates (Figure 7b, lower panel). We
observed that NeuroD was also selectively retained by
IgG-agarose in CebpaT/+ lysates (Figure 7b, upper panel),
indicating a complex formation with C/EBPα  in vivo.
While these results are fully consistent with the existence
of C/EBPα-NeuroD complexes in forebrain neurons, we
could not rule out that such complexes formed post-lysis.
We therefore transfected Q2bn cells separately with FLAG-
C/EBPα and Myc-NeuroD expression vectors and mixed
lysates from these cells prior to co-immunoprecipitation.
This did not lead to detectable complex formation,
whereas C/EBPα-NeuroD complexes were readily detecta-
ble in lysates of Q2bn cells cotransfected with the two
expression vectors (Figure 7c). Finally, to address the issueNeural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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C/EBPα/β and NeuroD are bound to the Fos, Egr1, and Egr2 promoters in vivo Figure 4
C/EBPα/β and NeuroD are bound to the Fos, Egr1, and Egr2 promoters in vivo. (a,d,g) In vivo detection of Fos, Egr1, or Egr2 
promoter occupancy by C/EBPα/β and NeuroD using ChIP analysis. The schemes illustrate the Fos, Egr1, and Egr2 promoter 
regions amplified by PCR in their 5' UTR (nucleotides -453 to -126, 1220 to 1361, and -96 to 72, respectively). The large black 
boxes indicate the predicted DNA binding sites (bs) for C/EBP and NeuroD. The small boxes indicate the position of the prim-
ers used for PCR amplification. ChIP assays were performed using E16.5 wild-type forebrain lysates and antibodies against 
NeuroD, C/EBPα and β, and demonstrated that these proteins are recruited to the three promoters. Input corresponds to 
PCR reactions containing 0.5% of the total amount of chromatin used in IP reactions. (b,e) To confirm the specificity of the 
results, IPs from each antibody were also analyzed by PCR with primers specific for a region of the Fos gene located in the 3' 
UTR, or for a region of the Egr1 gene located in exon 4 as indicated in the schemes. (c,f,h) qPCR analysis was used to quantify 
the relative amounts of DNA obtained by ChIP for the Fos (c), Egr1 (f), and Egr2 (h) promoters. DNA quantities (expressed as 
percentages of input) were compared for specific IPs versus Ig IP samples (see Materials and methods). The corresponding p 
values are indicated: *p < 0.002, **p < 0.02 for Egr1; *p < 0.0001, **p < 0.005 for Fos; *p < 0.0001, **p < 0.002 for Egr2. Error 
bars represent the standard error based on three independent experiments.
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of whether the C/EBPα-NeuroD interaction was direct we
performed glutathione S-transferase (GST) pull-downs
using C/EBPα-GST fusions of the conserved carboxy-ter-
minal bZIP or amino-terminal transactivation domain
(TAD) and in vitro translated NeuroD. Of these, NeuroD
associated strongly with the C/EBPα bZIP and only
weakly with the TAD. Consistent with the high conserva-
tion of the bZIP domain between C/EBP isoforms, a GST
fusion of the C/EBPβ bZIP region was also able to pull
down NeuroD (Figure 7d). Together, these results show
that NeuroD can interact with C/EBPs through their con-
served bZIP region. Since C/EBPα-NeuroD complexes can
be isolated from both transfected cells and forebrain sug-
gests that these molecules are co-expressed and interact in
neurons.
C/EBP depletion leads to defective cortical dendritic 
differentiation in vivo
We next addressed the role of C/EBPs in neuronal devel-
opment. Mice lacking C/EBPα die at birth [19], combined
Cebpa and Cebpb null alleles are embryonic lethal, and
mice carrying three Cebpa and Cebpb null alleles die at
BDNF dependent expression of Fos, Egr1 and Egr2 is affected in mice with compound Cebpa/b null mutant alleles Figure 5
BDNF dependent expression of Fos, Egr1 and Egr2 is affected in mice with compound Cebpa/b null mutant alleles. (a-c) qRT-
PCR analysis was performed on mRNA obtained from E13.5 primary cortical neurons of wild-type and different genotypes for 
Cebpa/b null mutants as indicated. After 3DIV, the neurons were either left unstimulated or stimulated with 5 ng/ml of BDNF 
for 1 hour. The mRNA levels are relative, after normalization to gapdh, considering the levels for the stimulated wild-type cor-
tical neurons as 100. Error bars represent the standard error obtained from three animals for each genotype. P < 0.0001 for all 
induced samples of mutants compared to wild type. (d) BDNF/TrkB dependent signaling in primary cortical neurons with 
mutant Cebpa/b. E13.5 cortical neurons derived from wild-type or different genotypes for Cebpa/b null mutants after 3DIV 
were either left unstimulated or stimulated with 5 ng/ml of BDNF for 5 minutes. Cell lysates were subjected to SDS-PAGE fol-
lowed by immunoblotting with an antibody against the phosphorylated forms of ERK (p42/p44). The blots were re-probed with 
an anti-phospho-AKT antibody, and a second time with an antibody against α-tubulin to control for the amount of protein 
loaded.
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The presence of CEBPα/β and NeuroD on the Fos, Egr1 and Egr2 promoters is dependent on Trk receptor signaling Figure 6
The presence of CEBPα/β and NeuroD on the Fos, Egr1 and Egr2 promoters is dependent on Trk receptor signaling. (a-c) In 
vivo detection of Fos, Egr1 and Egr2 promoter occupancy by C/EBPs and NeuroD in the absence of multiple trkB/C alleles. ChIP 
analysis was performed three times on a pool of four newborn forebrain lysates from wild-type (wt) and trkB-/-;trkC+/- mice 
using antibodies specific for C/EBPα, C/EBPβ, NeuroD, and acetylated-H3 (Ac-H3). Following ChIP analysis the samples were 
subjected to qPCR, and the DNA quantification was calculated as percentage of the input. In all cases, no PCR product was 
detected in the absence of DNA. The p value refers to the difference between wild-type and mutant animals. (d,e) Control 
experiments. (d) H3 ChIP analysis and qPCR were performed with primer pairs located in the Egr2-coding region. A similar 
amount of PCR product was detected in wild-type and mutant animals. (e) Cebpa, Cebpb and Neurod mRNA levels were not 
affected in the absence of Trk signaling. qRT-PCR was performed on total mRNA from newborn forebrain of wild-type (grey 
bars) and trkB-/-;trkC+/- (red bars) mice using primers specific for Cebpa, Cebpb and Neurod. After normalization to gapdh, mRNA 
levels were expressed relative to those for the wild-type animals, which were given the arbitrary value of 1. Error bars repre-
sent the standard error based on three independent experiments. *p < 0.05, **p < 0.002.
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The bHLH transcription factor NeuroD co-immunoprecipitates and physically interacts with C/EBPα and β Figure 7
The bHLH transcription factor NeuroD co-immunoprecipitates and physically interacts with C/EBPα and β. (a) Co-immuno-
precipitation (IP) assay and western blot analysis. Q2bn cells were transfected as indicated, and lysates were subjected to a Co-
IP assay with an anti-Flag antibody and were immunoblotted (WB) with anti-Myc and anti-Flag antibodies. Direct WB analysis 
was used to monitor protein expression levels. (b) WB, using an anti-NeuroD antibody, of TEV-released IgG pull down of 5 
mg nuclear extracts from E16.5 forebrain of either CebpaTAP/+ (T/+, lane 1) or +/+ (lane 2) mice; 100 μg of input lysate (+/+) 
was loaded in lane 3. Note the specific presence of NeuroD (50 kDa) in the T/+ pull down. The blot was reprobed with an 
anti-C/EBPα antibody showing the specific pull down of C/EBPα (42 kDa and 30 kDa isoforms) in the T/+ sample (lane 1). C/
EBPα in 100 μg of nuclear extract was below detectable levels by WB (lane 3). (c) NeuroD does not associate with CEBPα 
upon mixing lysates from myc-NeuroD transfected cells with lysates from flag-C/EBPα transfected cells.(d) Direct interaction 
of NeuroD to C/EBPα and β. In vitro translated NeuroD was subjected to a pull down assay using the indicated GST fusion 
proteins: GST-alone, GST-C/EBPβ-bZIP. GST-C/EBPα-bZIP., GST-C/EBPα-TAD. Autoradiograph revealed that NeuroD pref-
erentially bound the bZIP domain of C/EBPα or β. *Radiolabeled.
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birth [16]. Therefore, to facilitate the analysis we used
conditional inactivation of the Cebpa gene using a floxed
Cebpa allele (Cebpalx allele [20]) and a Nestin-Cre trans-
gene (NesCre [5]), and mice homozygous for the Cebpb
null allele. Southern blot analysis showed that NesCre
recombination of the Cebpalx allele was virtually complete
in the CNS at postnatal day 0 (P0; supplemental Figure 3
in Additional data file 1). Moreover, as the co-expression
of Cebpa/b in neurons suggested that they could function
in a redundant manner, we also combined the two muta-
tions. In this case the double mutant (Cebpalx/lx;Cebpb-/-
;NesCretg/+) died at birth, whereas mutants carrying up to
three Cebpa and Cebpb deleted alleles (Cebpalx/lx;Cebpb-/
+;NesCretg/+, and Cebpalx/l+;Cebpb-/-;NesCretg/+) were viable
and used in this analysis. Histological analysis of P0 corti-
ces showed no gross morphological defects or alteration
of cortical layering upon inactivation of up to three Cebpa
and Cebpb alleles (Figure 8a–f). Likewise, expression of
the general neuronal markers NeuN (Figure 8g, h) and
βIII-tubulin (Tju1; Figure 8i, j) was not decreased even in
Cebpalx/lx;Cebpb+/-NesCretg/+ cortices, nor was any differ-
ence seen in expression of the glial marker glial fibrillary
acidic protein (GFAP) (Figure 8k, l). No imbalance in neu-
ronal versus glial lineage differentiation was therefore
detected. When markers specific for neuronal dendrites
(microtubule-associated protein 2, MAP2) and axons (68
kDa neurofilament protein, NF68) were analyzed, MAP2
staining of cortical dendrites was not diminished upon
deletion of two Cebpa or Cebpb alleles, but was severely
disrupted in the absence of three alleles (Figure 8m–r).
Quantification showed that loss of three alleles addition-
ally led to a significant decrease in the amount of MAP2
present in the forebrain (Figure 8s, t); no difference in
axonal NF68 staining (data not shown) or total amount of
NF68 (Figure 8u, v) was observed, indicating intact axonal
differentiation. Given the previously reported regulation
of MAP2 by NeuroD [21], NeuroD protein expression in
Cebpa/b deficient brains was investigated and found to be
normal (Figure 9a, b). We also investigated whether
MAP2 expression was down-regulated upon loss of Cebpa/
b; this was found not to be the case, as MAP2 expression
at the mRNA level was not affected (Figure 9c). We there-
fore propose that the observed reduction in MAP2 protein
is due to loss of MAP2-containing dendritic structures.
Another possibility could be defective mRNA localization
and translation, leading to reduced accumulation of
MAP2 protein.
The possibility remained that the differences observed in
dendritic differentiation reflected a developmental delay,
rather than a defect. We therefore performed similar anal-
yses with 12-week-old mice. Also in this case, cortical lay-
ering (as determined by cresyl violet staining; Figure 10a,
b) and neuronal numbers (assayed by NeuN immunos-
taining; Figure 10c, d) were unaffected. Immunoblotting
confirmed equivalent levels of NeuN (Figure 10e, f), βIII-
tubulin (Figure 10g) and the glial marker GFAP (Figure
10h, i), whereas the defect in MAP2 staining in Cebpalx/
lx;Cebpb+/-;NesCretg/+ mice (compared to Cebpalx/lx;Cebpb+/-
controls) was still persistent (Figure 10j, k). Immunoblot-
ting confirmed the decrease in MAP2 protein levels (Fig-
ure 10l, m). Together, these data indicate a role for C/
EBPα/β in cortical dendritic differentiation. To further
support this conclusion we measured the thickness of api-
cal primary and secondary dendrites of pyramidal neu-
rons located in the primary somatosensory cortex. The
mean thickness of apical primary dendrites in Cebpalx/
lx;Cebpb+/-;NesCretg/+mice was found to be reduced by 10%
compared to Cebpalx/lx;Cebpb+/- controls (2.00 ± 0.02 μm
and 2.24 ± 0.115 μm, respectively; Figure 10m). Similarly,
the secondary dendrites were 7% thinner in mutants com-
pared to control mice (0.79 ± 0.02 μm and 0.85 ± 0.013
μm, respectively; Figure 10n). Although the differences
observed in both cases are not statically significant (p >
0.05) by ANOVA analysis, they are consistent with C/EBPs
being involved in dendritic differentiation function.
Discussion
The identification of transcriptional targets for signaling
by neurotrophin receptors is fundamental to understand-
ing the effects of neurotrophins on neuronal gene expres-
sion, differentiation and function. We here provide
evidence that, in neuronal cells, C/EBPα and -β form a
complex with NeuroD, and that these factors are recruited
to the BDNF responsive Fos, Egr1 and Egr2 promoters in a
manner dependent on Trk receptor signaling in vivo.
Reducing the levels of C/EBPα and -β led to reduced Fos,
Egr1 and Egr2 expression in response to BDNF in primary
neuronal cultures, and to impaired terminal dendritic dif-
ferentiation revealed by decreased levels of MAP2 in corti-
cal dendrites in vivo. Together, these results identify
NeuroD-C/EBP complexes as mediators of Trk signaling,
and identify the IE genes Fos, Egr1 and Egr2  as down-
stream targets for this pathway.
Nuclear mediators of neurotrophin signaling
Neurotrophins have multiple functions during CNS
development, and mediate neuronal survival, migration,
differentiation and function. These processes require acti-
vation of specific downstream targets. For example, the
PI3 kinase-AKT-Foxo pathway is important for neuronal
survival downstream of growth factor-induced signaling
[22], and both PI3 kinase-AKT and MAPK pathways are
involved in similar functions downstream of TrkB recep-
tor-induced signaling in vivo [15,23] whereas the phos-
pholipase Cγ (PLCγ)-CamK-CREB pathway regulates
hippocampal plasticity downstream of TrkB [3]. Cebpb has
been previously shown to be a neuronal transcriptional
target downstream of the nerve growth factor (NGF)
receptor (TrkA) in PC12 cells [24]. Evidence exists indicat-Neural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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Cortical dendritic differentiation is affected in mice carrying decreasing amounts of functional Cebpa/b alleles Figure 8
Cortical dendritic differentiation is affected in mice carrying decreasing amounts of functional Cebpa/b alleles. (a-f) Cresyl vio-
let staining showing a normal lamination pattern in newborn mutant and control mice. (g,i,k) Representative western blots of 
NeuN, Tju1, and GFAP protein levels in P0 cortices of mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) 
mice. To control for protein loading, blots were re-probed with anti-PLCγ, anti-α-tubulin, and anti-Erk1 respectively. (h,j,l) 
Densitometric analysis of NeuN, Tju1, and GFAP protein levels in P0 cortical lysates from mutant and control mice. P > 0.05 in 
all cases. (m-r) MAP2 immunostaining in newborn Cebpalx/lx, Cebpalx/lx;NesCretg/+, Cebpb-/-, and Cebpalx/lx;cebp+/- mouse cortices 
compared to cortices with decreasing amounts of functional Cebpa/b alleles, Cebpalx/lx;Cebpb+/-;NesCretg/+ (r), Cebpalx/+;Cebpb-/-
;NesCretg/+ (s). (s,u) Representative western blots of MAP2 and NF68 protein levels in P0 cortices of mutant (Cebpalx/lx;Cebpb+/
-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) mice. To control for protein loading, blots were re-probed with anti-PLCγ and 
anti-Erk1 antibodies respectively. (t) Densitometric analysis of MAP2 protein levels in cortical lysates of control and Cebpa/b 
mutant mice (*p = 0.002, compared to control Cebpalx/lx;Cebp+/-). (v) Densitometric analyses of NF68 protein levels in cortical 
lysates of controls and Cebpa/b mutant mice. Soms, somatosensory cortex; CP, cortical plate; V and VI, indicate cortical layers 
V and VI, respectively. Arrows in (h) indicate the kDa of the bands recognized by NeuN antibodies. Scale bars: 100 μm (b-g); 
50 μm (n-s).
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NeuroD expression is normal in Cebpa/b and trkB/C deficient brains Figure 9
NeuroD expression is normal in Cebpa/b and trkB/C deficient brains. (a) NeuroD protein expression in Cebpa/b deficient brains 
or trkB/C deficient brains compared to controls. Blots were re-probed with anti-Sp3 antibodies to control for protein loading. 
P > 0.5 in both cases. (b) Densitometric analysis of NeuroD protein levels in cortical lysates of controls, Cebpa/b and trkB/C 
mutant mice. (c) MAP2 mRNA levels were not affected in Cebpa/b deficient brains. qRT-PCR was performed on total mRNA 
from newborn forebrains of control (Cebpalx/lx;Cebpb+/-) and mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) mice using primers specific 
for MAP2A/2B isoforms. After normalization to ubiquitin, mRNA levels were expressed relative to those for the control ani-
mals, which were given the arbitrary value of 1. Presented is a representative result of two independent experiments. Standard 
error is for three animals of each genotype.
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Neocortical development in mice with compound Cebpa/b null alleles Figure 10
Neocortical development in mice with compound Cebpa/b null alleles. Coronal sections of adult (12 weeks old) cortices of 
control (Cebpalx/lx;cebp+/-) and mutant (Cebpalx/lx;Cebpb+/-;NesCretg/+) mice were stained with (a,b) Cresyl violet, or immunos-
tained for (c,d) NeuN. (e,h) Representative western blots for NeuN and GFAP protein levels in adult cortical lysates from 
control and mutant mice. To control for protein loading, blots were re-probed with an anti-Erk1 antibody. (f,g,i) Densitomet-
ric analysis of NeuN, Tju1, and GFAP protein levels in adult cortical lysates of control and mutant mice. (j,k) Immunostaining 
for MAP2 in control and mutant mice. (l) Representative western blots of MAP2 protein levels in adult cortices of mutant 
(Cebpalx/lx;Cebpb+/-;NesCretg/+) and control (Cebpalx/lx;Cebpb+/-) mice. To control for protein loading, blots were re-probed with 
anti-PLCγ antibodies. (m) Densitometric analysis of MAP2 protein levels reveals significant decrease in mutant compared to 
control mice. *P = 0.019. (n,o) Mean thickness of primary and secondary dendrites of pyramidal neurons located in the pri-
mary somatosensory cortex (visualized with the Golgi method). II to VI indicate the different cortical layers. Scale bars (a-d,j,k): 
100 μm.
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ing that NeuroD is responsive to neurotrophin signaling
in vivo. NeuroD is highly expressed in different tissues,
including the developing neurons of the peripheral nerv-
ous system (PNS) and CNS, reaching its highest expres-
sion during differentiation in the cerebral cortex [25]. In
the PNS, NeuroD is required for survival and differentia-
tion of inner ear sensory neurons during later stages
[26,27]. The loss of these sensory neurons in the vestibu-
lar-cochlear ganglia (VCG) of neuroD null mice resembles
the phenotypes found in mice lacking the receptors TrkB
or TrkC (reviewed in [28]). Moreover, the expression of
trkB or trkC in the VCG of neuroD null mice was signifi-
cantly reduced, [26], supporting a link between NeuroD
and TrkB/C in the survival of newly differentiating inner
ear sensory neurons. Similarly, dentate granule neurons of
the CNS fail to mature in neuroD/nex1  double mutant
mice, indicating that these molecules are critical not only
for the survival of early differentiating neurons, but also
for their terminal differentiation [29,30]. Although no
such phenotype was observed in the neocortex of neuroD/
nex1 animals, this may be explained by NeuroD family
members being functionally redundant.
We have identified NeuroD-C/EBP complexes as novel
mediators of Trk signaling in vivo. The finding that inhibi-
tion of these complexes (through deletion of Cebpa and
Cebpb alleles) has effects on cortical differentiation similar
to those seen by reduction of Trk signaling during devel-
opment (through disruption of Ntrk2 and Ntrk3 alleles;
supplemental Figure 4 in Additional data file 1, and pre-
vious work in which we have shown that TrkB/C cooper-
ate in promoting the survival of differentiating
hippocampal and cerebellar granule neurons [17], and
that TrkB regulates functions throughout the formation of
the cerebral cortex, including dendrite neuronal differen-
tiation [5]) is, furthermore, consistent with Trk signaling
through NeuroD-C/EBP being required for MAP2 induc-
tion and dendrite growth. Given that C/EBPs and NeuroD
are induced during neuronal lineage commitment in vitro,
it is interesting to speculate that their appearance allows
Trk receptor signaling to regulate genes involved in subse-
quent terminal neuronal differentiation and function.
Of the targets found to be affected in this study, Fos and
Egr1 have both been implicated in dendrite formation in
PC12 cells [31,32]. Genetic ablation of Fos, Egr1 or Egr2
has not been reported to affect dendrite differentiation in
vivo, suggesting that the combined downregulation of
multiple targets leads to the observed effects on neuronal
dendrite differentiation. It is, however, equally possible
that some of the NeuroD-C/EBP targets are involved in
neuronal function, since Egr1  has been reported to be
required in the CNS for long-term synaptic plasticity
(LTP) in the dentate gyrus [33]. The known functions of
the affected genes are, therefore, consistent with the
observed differentiation phenotype, and suggest a role for
C/EBPs in the generation of LTP. However, given the pos-
sibility of functional redundancies, further genetic analy-
sis will be required to resolve this issue.
We did not observe any effects of C/EBP depletion on
gross CNS morphology or the distribution or number of
neurons and glial cells, as determined by histological
analysis and quantification of NeuN and GFAP. Previous
reports [13,14] have shown that high levels of dominant-
negative C/EBP were able to inhibit neurogenesis. Our
genetic data do not, at this point, confirm a role for C/
EBPs in neuronal-glial lineage decisions. However, in
addition to C/EBPα and β, C/EBPδ and ε are also
expressed in the CNS and may be able to compensate for
loss of the α and β isoforms. In addition, due to the early
embryonic lethality of mice lacking all Cebpa and Cebpb
alleles, one wild-type allele was intact in our analysis,
which may be sufficient for any commitment step. It
should be noted that the use of high levels of dominant
negative C/EBPs may affect other related transcription fac-
tors (such as C/ATF and CREB/CREM), and confirmation
of the proposed C/EBP function in neuronal lineage com-
mitment by genetic means will still be important to finally
resolve this issue.
Recruitment of C/EBP-NeuroD complexes to target 
promoters
The promoter elements in the Fos, Egr1 and Egr2 promot-
ers that recruit C/EBPα/β and NeuroD have significant
homology, but in the case of Egr1 and Egr2 do not contain
a consensus Ebox. This raises the possibility that the C/
EBP-NeuroD complexes that form in vivo in neuronal cells
expressing these factors (as determined by TAP-mediated
pull down from mouse forebrain tissue) are recruited
through a single binding site for C/EBP, with little or no
interaction between NeuroD and DNA. This notion is
supported by the observation that mutation of the Fos
promoter Ebox had no effect on Fos promoter activity in
transient transfection assays, whereas simultaneous muta-
tion of both the C/EBP site and the Ebox significantly
decreased promoter induction by BDNF.
The recruitment of NeuroD and C/EBPα/β to IE gene pro-
moters was impaired in vivo when the levels of Trk signal-
ing were decreased by inactivation of Ntrk2/Ntrk3. This
result demonstrates that Trk-mediated signaling regulates
the association of these factors with chromatin, and the
observation that NeuroD and C/EBP recruitment were
highly correlated is consistent with these factors being
recruited as a complex, as discussed above. Importantly,
lowering the level of C/EBP through Cebpa/Cebpb inactiva-
tion decreased the inducibility of all three IE gene promot-
ers in response to BDNF, providing a direct link between
the level of C/EBP (and by inference C/EBP-NeuroD com-Neural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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plexes) available and neurotrophin-mediated gene activa-
tion. While C/EBPs, therefore, are an essential component
of TrkB/TrkC mediated IE gene activation, the events link-
ing Trk signaling to C/EBP and/or NeuroD remain to be
fully understood at this point. Both C/EBPs and NeuroD
are known to be phosphorylated in response to extracellu-
lar signaling; however, the physiological relevance of
these phosphorylation events are yet to be addressed
genetically. Perhaps most relevantly, from in vitro studies,
phosphorylation of C/EBPβ Thr188 by ERK, and Thr217
by ribosomal S6 kinase (Rsk), both of which are kinases
downstream of MEK [34], have been proposed to be
required for their role in neuronal lineage commitment
[13,14]. We find that Trk-mediated IE gene induction
depends on the Shc adaptor-binding site, a principal func-
tion of which is to mediate high-level sustained ERK acti-
vation in cultured neurons [15]. It is therefore possible
that, also in the context of a NeuroD-C/EBP complex, this
pathway regulates C/EBP activity. Experiments to address
this question genetically are currently underway.
In summary, we have shown here that C/EBPα and Neu-
roD form complexes in vivo and in vitro. These may define
a novel class of C/EBP-bHLH transcription factor com-
plexes of widespread importance, as we have recently
shown that a similar interaction occurs between C/EBPα
and SREBP-1 in hepatocytes [35]. ChIP analysis and
genetic depletion demonstrated that recruitment of C/EBP
and NeuroD to IE gene promoter chromatin occurred
concurrently in a Trk-dependent manner, and was
required for IE gene induction by neurotrophins. The
physiological result of C/EBP depletion was reduced
MAP2 expression and impaired cortical dendritic differen-
tiation. We have, therefore, identified C/EBP-NeuroD
complexes as novel mediators of Trk signaling, and pro-
vide evidence that such complexes function in late stages
of neuronal development to promote terminal neuronal
differentiation.
Materials and methods
RNA preparation for microarray analysis and RT-PCR
RNA was isolated from E15.5 cortical neurons of +/+ and
trkBSHC/SHC mice with TRIzol according to the protocol
supplied by the manufacturer (GIBCO Life Technologies
(now Invitrogen), Milan, Italy), and labeled according to
the one-cycle eukaryotic target labeling protocol from
Affymetrix (Santa Clara, CA, USA). The samples were
hybridized to Affymetrix Murine Genome U74Av2 GENE-
Chips. For RT-PCR or qPCR, cDNA was prepared from
total RNA using random hexamer primers and MuLV
reverse transcriptase (Roche, Milan, Italy) or Ready-to-go
T-primed First Strand Kit (Amersham Biosciences, Milan,
Italy) as described by the manufacturers. The sequences of
the primers used for the different PCR reactions are listed
in Table 1.
DNA constructs
The constructs pMSRF/cebp, pMcebp/ebox, and pMebox
were created as previously described [36]. Mutations in
the pMSRF/cebp and pMcebp/ebox constructs were intro-
duced as described [37], whereas for the pMebox con-
struct the QuickChange Site-directed Mutagenesis Kit was
used (Stratagene, Milan, Italy). The oligonucleotide prim-
ers used to generate pMSRF/cebp, pMcebp/ebox and pMe-
box constructs carried the following mutations
(underlined), respectively: tgtccatcggaggacatctgcgtcagcag-
gtttccacggcc, tgtccatattaggaacgctgcgtcagcaggtttccacggcc,
and tgtccatattaggaaatctgcgtcagcaggtttccacggcc. C/EBPα
was introduced as BamHI-EcoRI fragments in pcDNAI
(Invitrogen, Milan, Italy) for in vitro labeling [38], and in
pcDNA3.1 (Invitrogen) for transfection. Mouse NeuroD
full-length cDNA was obtained by RT-PCR using RNA iso-
lated from cortical neurons and the primers BamHI/5'-
cgggatccgtggaaacatgacc-3' and 5'-ggaattcactgacgtgcctcta-3'/
EcoRI.
Cultures of cortical progenitors and postmitotic neurons
Cortical progenitors, as well as postmitotic neurons, from
mouse embryos were cultured according to previously
described methods [15,39]. Briefly, cortices were collected
from E12-13 mouse embryos, triturated, and then plated
on poly-L-lysine (at different densities depending on the
final experiment). The culture medium consisted of Neu-
robasal medium (GIBCO BRL (now Invitrogen), Milan,
Italy), 0.5 mM glutamine, penicillin-streptomycin, 1% N2
supplement (GIBCO BRL), and basic fibroblast growth
factor (bFGF) (40 ng/ml; R&D Systems, Milan, Italy).
After 48 hours, medium was replaced with the same
medium containing 2% B27 supplement (GIBCO BRL)
instead of 1% N2 supplement. Postmitotic neurons were
prepared from cerebral cortices of E15.5 mouse embryos
derived from crosses of wild-type or trkBSHC/SHC
homozygous mice. Cortical neurons were cultured and
BDNF stimulated as described [15]. Purified recombinant
BDNF (Regeneron Pharmaceuticals, Inc., Tarrytown, NY,
USA) was added to the culture medium at a concentration
of either 5 or 50 ng/ml, as indicated.
Immunocytochemistry
Cortical progenitors after either 1 or 4 days in vitro (DIV)
were fixed in 4% paraformaldehyde (PFA) for 20 minutes.
Washes were performed with 10 mM phosphate-buffered
saline (PBS)/glycine to neutralize the PFA. The cells were
permeabilized with 0.5% NP-40/PBS for 5 minutes.
Blocking solution was added for 1 hour (10% NHS, 0.3%
Carrageenan Lambda (Sigma, Milan, Italy), 0.5%
TritonX100 in 50 mM TBS) at room temperature, fol-
lowed by incubation with either a mouse monoclonal
anti-MAP2 antibody (1:300, clone AP20, ChemiconMi-
lan, Italy) or a mouse monoclonal anti-Nestin antibody
(1:300, clone 401, Chemicon) in 1% normal horse serumNeural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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(NHS), 0.3% Carrageenan Lambda, 0.5% TritonX100, 50
mM Tris-buffered saline (TBS), O/N at 4°C. Immunos-
tainings were visualized using a fluorescein-conjugated
goat anti-mouse IgG (H+L) (1:200 in TBS, Jackson IR,
Milan, Italy). The slides were mounted with Vectashield
mounting medium (Vector H2000, Milan, Italy).
Transfection of cortical neurons and luciferase assay
Cortical neurons were plated at 3 × 106 cells per 60 mm
well. Transfections were carried out on either 3 or 4DIV
using Lipofectamine 2000 reagent (Invitrogen) according
to the manufacturer's protocol. Briefly, one 60 mm well of
cells was transfected with 2.3 μg of reporter plasmid plus
3 μg of the plasmid ras sarcoma virus long terminal repeat
containing the Escherichia coli beta-galactosidase gene
(pRSV-β-gal). Then, 24 hours after transfection, cells were
left unstimulated or stimulated with 50 ng/ml of BDNF
for 2 hours. Cells were then lysed in 250 μl of Triton lysis
buffer (100 mM potassium phosphate pH 7.8, 0.2% Tri-
ton X-100, 1 mM dithiothreitol (DTT)). Cell debris was
removed by centrifugation, and the lysates were used in
luciferase and β-gal assays. The luciferase activity was
measured using a Lumat LB 9507 luminometer (Berthold
Technologies Wildbad, Germany). The fold induction was
defined as the ratio of β-gal normalized luciferase activity
in lysates of stimulated cells relative to the normalized
luciferase activity from unstimulated cells.
Co-transfection assay
Plasmids used for cotransfections included pcDNA3.1
(Invitrogen) driving the expression of C/EBPα or NeuroD,
and a wild type (pWT) or mutated (pMcebp/ebox) Fos
promoter driving expression of luciferase. NIH3T3 cells
were grown to 60% to 80% confluence in 30 mm wells
and transfected with a total of 1.5 μg of DNA including
250 ng of the luciferase reporter plasmid and 250 ng of
pRSV-β-gal plasmid for normalization. Cells were trans-
fected using FuGENE 6 (Roche) according to the manufac-
turer's protocol. After 24 hours, cells were harvested,
lysed, and the β-galactosidase and luciferase activities
were measured as described above.
Co-immunoprecipitation assay and western analysis
pCMV-Tag3 vector (Stratagene, Milan, Italy) was used to
express NeuroD possesssing one Myc-epitope tag, and
pcDNA3.1 (Invitrogen) was used to express C/EBPα pos-
sessing one Flag-epitope tag. Q2bn cells were grown in
DMEM supplemented with 8% fetal bovine serum and
2% chicken serum, transfected using calcium phosphate,
and harvested 24 hours after transfection. Cells were dis-
rupted in lysis buffer (50 mM Tris pH 7.4, 1.5 mM MgCl2,
100 mM NaCl, 0.5% Triton X-100) supplemented with a
protease inhibitor cocktail (Roche) on ice for 15 minutes,
and then incubated at room temperature for 30 minutes
with 0.25 u/μl of benzonase (Sigma). After clarification by
centrifugation, lysates were subjected to Co-IP using 20 μl
of anti-Flag M2 affinity gel beads (Sigma) at 4°C over-
night (O/N). The beads were collected and washed, and
the bound proteins were eluted by a competition with 3X
FLAG peptide (Sigma), and analyzed by SDS-PAGE fol-
lowed by western blotting using anti-Myc tag antibody
(1:2000, Ab9106, Abcam, Cambridge, UK) and anti-Flag
Table 1: Primer sequences used for RT-PCR, q PCR and ChIP
Gene Sense Antisense
RT-PCR Cebpa aaggccaagaagtcggtgga cagttcacggctcagctgtt
Cebpb gcgcgagcgcaacaacatc tgcttgaacaagttccgcag
Neurod tcaaccctcggactttcttg gcagtcagttagggggcttt
Ubiquitin tggctattaattattcggtctgcat gcaagtggctagagtgcagagtaa
qPCR Egr1 gttatcccagccaaacgactc ggttcaggccacaaagtgtt
Fos cccatccttacggactccc gagatagctgctctactttgcc
Egr2 ggaccacctctactctccg tgggatcataggaatgagacctg
Cebpa gtcactggtcaactccagcac caagaacagcaacgagtaccg
Cebpb ggagacgcagcacaaggt agctgcttgaacaagttccg
Neurod atgaccaaatcatacagcgagag tctgcctcgtgttcctcgt
MAP2A/B aaagttgcctccagttccattt tctttgattccgtgggcattt
gapdh aactttggcattgtggaagg acacattgggggtaggaaca
ChIP Promoter Egr1 tgcccaccactcttggatgg ttcaagggtctggaacagca
CD Egr1 gttatcccagccaaacgactc ggttcaggccacaaagtgtt
Promoter Fos gctcgccttctctgcctttc gcgctctgtcgtcaactcta
Promoter Fos* tccctccctcctttacacag cccgtcttggcatacatctt
3' UTR Fos ggctacactgtgagatccta acaactgccagggccattag
Promoter Egr2 gccctgttcctcagtccata gccaggagttgctggtgtag
CD Egr2 ggaccacctctactctccg tgggatcataggaatgagacctg
For the ChIP experiments the same primers were used for both PCR and qPCR except where noted. *Additional primers used for Fos qPCR after 
ChIP. CD, coding region; UTR, untranslated region.Neural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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tag antibody (1:2500, Sigma). Analysis of pERK1/2 and
pAKT in stimulated cortical neurons derived from cerebral
cortices of E12.5 mouse embryos of controls and different
Cebpa and Cebpb mutants was carried out using western
blots as described [15]. The monoclonal anti-pERK1/2
antibody was used at 1:2000 (clone E10, New England
Biolabs, Frankfurt, Germany), the rabbit polyclonal anti-
pAKT (Ser473) was used at 1:1000 (Cell Signaling, Frank-
furt, Germany), and the monoclonal anti-α-tubulin anti-
body was used at 1:20.000 (clone DM1A, Sigma).
GST pull down assay
The GST fusions C/EBPβ bZIP (amino acids 231 to 328 of
chicken C/EBPβ) and C/EBPα bZIP (amino acids 256 to
358 of rat C/EBPα) were constructed by PCR amplifica-
tion and cloning into pGEX4T-1 (Pharmacia, Milan,
Italy). GST C/EBPα TAD (amino acids 1 to 96) has been
described [40]. 35S-labeled NeuroD was prepared using
the Promega TNT T7 system and L-35S-methionine (Amer-
sham Biosciences) according to the manufacturer's sug-
gestions. Pull down experiments were carried out by pre-
incubating 100 μl of bead suspension (corresponding to
about 500 ng protein) with 50 μl 10% bovine serum albu-
min (BSA) and 350 μl pull down buffer (50 mM Tris pH
8, 250 mM NaCl, 0.5% NP40) for 30 minutes at room
temperature with gentle shaking. 35S-labeled protein (5
μl) was subsequently added, and the incubation was con-
tinued for 1 hour. The beads were then washed 3 times
with ice-cold NETN buffer (0.1 M NaCl, 1 mM EDTA, 10
mM Tris pH 8.0, 0.5% NP40), pelleted, and resuspended
in 20 μl of 2X SDS buffer (20% glycerol, 4% SDS, 10% β-
mercaptoethanol, 125 mM Tris-Cl pH 6.8, 0.2%
bromophenol blue). The samples were boiled for 5 min-
utes, and the beads were pelleted. The supernatants were
resolved by SDS-PAGE (12.5%). Labeled proteins were
detected on a Fuji BAS2040 phosphorimager (Milan,
Italy).
Tandem affinity purification
Wild-type (+/+) and CebpaTAP/+  (T/+) E16.5 forebrains
were dissected, and then lysed in hypotonic buffer (25
mM Tris pH 7.4, 50 mM KCl, 2 mM MgCl2, 1 mM EDTA,
1 mM DTT, protease inhibitors from Sigma) for 20 min-
utes on ice. The samples were centrifuged at 4,000 rpm for
20 minutes at 4°C to collect the nuclei, which were
washed in hypotonic buffer and resuspended in benzo-
nase buffer (50 mM Tris pH 7.4, 1.5 mM MgCl2, 100 mM
NaCl, 10% glycerol and 1 mM DTT and protease inhibi-
tors). Benzonase (Novagen, Milan, Italy) was then added
at 0.25 u/μl and left at room temperature for 25 minutes,
after which lysates were supplemented with 0.2% NP40
and left on ice for 10 minutes. The nuclear extracts were
collected by centrifugation at 14,000 rpm at 4°C for 20
minutes, and 5 mg of this were used in IP after a pre-clear-
ing step with proteinA sepharose beads (Pharmacia) at
4°C for 30 minutes. We added 20 μl rabbit IgG agarose
beads (Sigma) to the extracts and incubated them with
gentle rocking at 4°C for 2 hours. The beads were washed
three times with lysis buffer followed by TEV protease
buffer (10 mM Hepes-KOH pH 8.0, 150 mM NaCl, 0.1%
NP-40, 0.5 mM EDTA, 1 mM DTT). TEV protease (Invitro-
gen) was then added at 0.3 u/μl and left overnight at 4°C.
Proteins in the supernatant of centrifuged samples were
precipitated using acetone, dissolved in 20 μl of sample
buffer, and loaded on a 10% SDS-PAGE gel. Western blot
analysis was performed using an anti-NeuroD antibody
(1:500; D-20, SantaCruz, Milan, Italy) in 5% BSA.
Stripped membranes were re-probed with an anti-C/EBPα
antibody (1:500; 14AA, SantaCruz).
ChIP analysis
ChIP assays were performed essentially as previously
described [41]. E16.5 or P0 wild-type mouse forebrains
were quickly dissected, cut into small pieces, and incu-
bated for 10 minutes in 1% PFA at 37°C. The tissues were
collected, washed in PBS, and resuspended in lysis buffer
(1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1) con-
taining 1 mM phenylmethylsulphonyl fluoride (PMSF)
and 2 mg/ml aprotinin. After sonication, lysates were
cleared by centrifugation and diluted 10-fold with dilu-
tion buffer (0.01% SDS, 1% Triton 100X, 1.2 mM EDTA,
16.7 mM Tris-HCl pH 8.1, 150 mM NaCl). After a pre-
clearing step using a salmon sperm DNA/ProteinA agar-
ose slurry (50% slurry, Upstate, Milan, Italy), the
chromatin was incubated O/N at 4°C with either rabbit
Ig, or 2 μl of C/EBPα (14AA, SantaCruz), C/EBPβ (#3082
polyclonal, Cell Signaling), NeuroD (Santa Cruz), histone
H3 (Abcam), or acetylated histone H3 (Upstate) antibod-
ies. IP complexes were collected using protein A/G sepha-
rose beads, and washed twice with dilution buffer, once
with 500 mM NaCl, and once with Tris-EDTA buffer. After
the final wash, 250 μl of elution buffer (1% SDS, 0.1 M
NaHCO3) was added, and the beads were rotated at room
temperature for 15 minutes. The elute was supplemented
with 5 M NaCl and incubated for 4 hours at 65°C to
reverse the formaldehyde cross-linking. To analyze the
DNA, samples were treated with 40 ng/μl of proteinase K
(Merck, Milan, Italy) for 1 hour at 45°C, extracted with
phenol:chloroform, and ethanol-precipitated in the pres-
ence of glycogen as carrier. The final IP DNA products
were resuspended in 20 μl of 10 mM Tris-HCl and 1 mM
EDTA, of which 2 μl was used for PCR analysis with 50
pmol of each primer (Table 1) in a final volume of 50 μl.
Quantitative PCR
qPCR or qRT-PCR was performed using the DyNA-
moSYBR Green qPCR kit according to the manufacturer's
protocol (Finnzymes, Milan, Italy) using the primers indi-
cated in Table 1. For the ChIP, serial dilutions of IP DNA
were subjected to real time PCR. After running the qPCRNeural Development 2007, 2:4 http://www.neuraldevelopment.com/content/2/1/4
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reactions, crossing threshold (Tc) values were determined
for each sample. The Tc value was defined as the cycle at
which the fluorescence rises above a baseline threshold,
using iCycler software (MJ Research, Cambridge, MA). To
normalize for variations in the amount of starting DNA, a
ΔTc value was calculated by subtracting the Tc value for the
immunoprecipitated sample from the Tc value for the cor-
responding input DNA. DNA quantities were then
expressed as percentages of corresponding input using the
ChIP sample as a percentage of input = 2Δ(Tc) × 100. Only
when IP samples contained > 1.5 times as much DNA as
the Ig samples were they considered to have sufficient
DNA for analysis [42].
Transgenic mouse strains
The methods used to generate the knockouts of trkB, trkC,
and trkBSHC have been previously described [15,17], as
well as those used to generate the knockouts of Cebpa
(generously provided by Drs D Tenen (Harvard Univer-
sity, Boston MA, USA) and G Darlington (Baylor College
of Medicine, Houston TX, USA) and Cebpb (generously
provided by Drs PF Johnson and E Sterneck (National
Cancer Institute, Bethesda DC, USA), the floxed Cebpa
(generously provided by Dr YH Lee, Institute of Molecular
Biology, Accademia Sinica, Taipei, Taiwan), and the trans-
genic NestinCre mouse lines [5,19,20,43]. The C/EBPα-C-
TAP strain was generated according to [18] (O Ermakova
and C Nerlov, unpublished data).
Histology and protein expression levels
Histological and immunohistochemical (IHC) analyses
were carried out as described previously [3]. Brain tissue
biochemistry was performed as described [5]. The specific
antibodies used to evaluate neuronal differentiation were
NeuN (1:500 WB, 1:100 IHC, clone A60, Chemicon),
βIII-tubulin (1:10,000, clone Tuj.1, AbCam), GFAP (H-
50; 1:500, polyclonal, Santa Cruz), MAP2 (1:300, clone
AP20, Chemicon) and NF68 (AB1983; 1:250, polyclonal,
Chemicon). The antibodies anti-PLCγ-1 (1:2,000, mixed
monoclonal, Upstate), anti-Erk1 (1:3,000, monoclonal,
Zymed, Milan, Italy), and anti-α-tubulin (1:20,000, clone
DM1A, Sigma) were used to control for protein loading.
For the analysis of NeuroD protein expression, P0 cortices
from Cebpa/b and trkB/C mutants and controls were lysed
in (50 mM Tris pH 7.4, 1.5 mM MgCl2, 100 mM NaCl,
0.5% Triton X-100) supplemented with a protease inhib-
itor cocktail (Roche) on ice for 15 minutes, and then incu-
bated at room temperature for 30 minutes with 0.25 u/μl
of benzonase (Sigma). Western blot analysis was per-
formed using an anti-NeuroD antibody (1:500, D-20,
SantaCruz) in 5% BSA. Stripped membranes were re-
probed with an anti-SP3 antibody (D-20X; 1:1,000, poly-
clonal, SantaCruz). Densitometric analysis [44] of imaged
blots was used to compare the expression levels of pro-
teins in mutant and control brains, and was performed on
three different blots for each antibody. The ratios
obtained for mutant and control samples were compared
statistically using Student's t-test.
Golgi method and analysis of dendritic thickness
Mice were perfused with 4% PFA in phosphate buffer.
Brains were dissected and post-fixed in 4% PFA. Golgi
staining was performed according to the Golgi-Kopsch
method, as described previously [45]. Briefly, blocks of
brain tissue (approximately 2.5 mm thickness) were pre-
pared and soaked in a solution containing 2.5% potas-
sium-dichromate for 1 day at room temperature in the
dark. The solution was then replaced with fresh of 2.5%
potassium-dichromate solution, and tissues were incu-
bated for another 6 days. Tissues were then washed and
transferred to a solution containing 0.75% AgNO3. After 5
to 6 days, brain pieces were removed, washed in 40% and
20% ethanol, and cut into 80 μm coronal sections using a
vibratom (Leica, Heidelberg, Germany). Sections were
mounted on gelatin-coated slides and coverslipped with
Merkoglas (Merk, Darmstadt, Germany). Analysis of den-
dritic thickness was performed on Golgi-impregnated sec-
tions that were uniformly dark throughout the section.
Only dendrites that displayed no breaks in their staining,
and were not masked by other neurons or artifacts, were
evaluated. Quantitative three-dimensional analyses were
performed using a combined hardware-software system
(NeuroLucida, Microbrightfields Inc., Colchester, VT,
USA) controlling the x-y-z axis of the microscope (Axio-
scop Imaging, Zeiss, Rehlingen, Germany), and a micro-
scope-mounted video camera (Hitachi, Tokyo, Japan).
The three-dimensional reconstruction was done using a
100× objective (NA: 1.4; oil immersion) and the Neu-
roLucida system. Mean dendritic thickness was calculated
from the reconstructed dendrites with the help of Neu-
roExplorer (Microbrightfields Inc.). The mean, standard
deviation (SD), and standard error of the mean (SEM)
were calculated. ANOVA followed by a Newman-Keuls
test were used for statistical analysis, and were performed
using Prism 4.0 (Graph Pad, San Diego, USA).
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